Tech Company Financing Transactions
VentureMed Group Funding Round
On 10/29/2025, VentureMed Group raised $28 million in Series C investment from S3 Ventures and Endeavour Vision.
Transaction Overview
Company Name
Announced On
10/29/2025
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Series C
Investors
S3 Ventures (Lead Investor) (Brian Smith)
Endeavour Vision (Alexander Schmitz)
Proceeds Purpose
In addition to expanded commercial infrastructure, the funding will also advance VentureMed's clinical program and support new product development, including new applications in adjacent vascular settings.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
2865 N Reynolds Rd. 220A
Toledo, OH 43615
USA
Toledo, OH 43615
USA
Phone
Website
Email Address
Overview
VentureMed is an innovator in vessel preparation for the interventional treatment of peripheral artery disease (PAD). The company's FLEX Scoring Catheter technologies make vessel preparation simpler, quicker and more cost-effective.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gary Smith
Chief Operating Officer
Brent Cousino
Chief Scientific Officer
John Pigott
VP - Sales
Jeff Tully
Browse more venture capital transactions:
Prev: 10/29/2025: Seres Therapeutics venture capital transaction
Next: 10/29/2025: Homecourt venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs